• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Baxter

Baxter misses on revenue in Q2, cuts outlook amid ‘macroeconomic headwinds’

July 28, 2022 By Chris Newmarker

Baxter (NYSE:BAX) shares are down today on mixed second-quarter results, with the medtech giant reducing its full-year outlook amid supply chain challenges and inflationary pressures. BAX shares were down more than 10% to $59.66 apiece in morning trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical device companies, was up […]

Filed Under: Business/Financial News, Dialysis, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Baxter

Baxter’s Volara lung therapy system recall is Class I

June 23, 2022 By Sean Whooley

The FDA issued a notice today labeling the recall of the Baxter (NYSE:BAX) Volara lung therapy system as Class I, the most serious kind. Earlier this month, Baxter announced that it issued an urgent medical device correction for its Volara system for oscillation and lung expansion (OLE) therapy. To date, there has been one complaint […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Baxter, FDA, Hillrom

Baxter warns of risks around Volara lung therapy at home

June 2, 2022 By Sean Whooley

Baxter (NYSE:BAX) announced that it issued an urgent medical device correction for its Volara system for oscillation and lung expansion (OLE) therapy. The warning from Baxter for the Volara system — manufactured by Hillrom, which Baxter acquired for $12.5 billion last year — reinforces important safety information regarding a possible risk of the decrease in […]

Filed Under: Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Respiratory Tagged With: Baxter

Baxter expects sales growth momentum through 2025

May 25, 2022 By Sean Whooley

Baxter (NYSE:BAX) today issued long-term financial guidance that projects growth over the next three years. Shares of BAX were up 1.5% at $74.98 per share in midday trading today in response to the news. Deerfield, Illinois-based Baxter expects sales growth between 4% and 5% on a compounded annual basis from 2022 through 2025, with free […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Baxter

Thanks, mom! Medtech leaders reflect on Mother’s Day

May 6, 2022 By Jim Hammerand

Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised. As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built. We […]

Filed Under: Blog, Featured, News Well Tagged With: Ambu, Baxter, DePuy Synthes, Hologic, Intuitive Surgical, mother's day, qosina, Zimmer Biomet

Baxter posts Street-beating Q1 results, cites ‘positive momentum’ from Hillrom acquisition

April 28, 2022 By Danielle Kirsh

Baxter (NYSE:BAX) this week posted first-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based maker of products to kidney disease — and a host of other chronic and acute medical conditions — reported profits of $71 million, or 14¢ per share, on sales of $3.7 billion for the three months ended […]

Filed Under: Dialysis, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Baxter

Baxter-sponsored study supports use of hemodynamic monitoring to help predict outcomes

April 19, 2022 By Sean Whooley

Baxter (NYSE:BAX) announced today that study findings supported stroke volume and cardiac monitoring for predicting patient outcomes. The Baxter-sponsored study found that monitoring stroke volume and cardiac output trends for patients with critical conditions may offer vital insight into cardiac function and aid in predicting patient outcomes, including mortality. Deerfield, Illinois-based Baxter’s study findings were […]

Filed Under: Blood Management, Cardiovascular, Clinical Trials, Featured, Neurological, News Well, Patient Monitoring Tagged With: Baxter

FDA clears Baxter’s continuous renal replacement therapy system

April 5, 2022 By Sean Whooley

Baxter (NYSE:BAX) announced today that it received FDA 510(k) clearance for its ST Set in continuous renal replacement therapy (CRRT). Deerfield, Illinois-based Baxter designed the ST Set as a pre-connected, disposable, extracorporeal circuit that provides blood purification through a semipermeable membrane for use with the PrisMax or Prismaflex control units. The platform has been available […]

Filed Under: 510(k), Blood Management, Featured, Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: Baxter, FDA

Baxter settles with the SEC for $18M

February 23, 2022 By Chris Newmarker

The U.S. Securities and Exchange Commission announced today that Baxter will pay an $18 million penalty over foreign exchange trading practices that misstated the company’s earnings. In its annual report out today, Baxter said that it agreed to cease and desist from future violations, though it did not admit or deny the findings in the […]

Filed Under: Business/Financial News, Featured, Legal News, News Well, Wall Street Beat Tagged With: Baxter

Baxter warns of alarm malfunction on some infusion pumps

February 18, 2022 By Sean Whooley

Baxter (NYSE:BAX) announced today that it has issued an urgent safety communication regarding upstream occlusion alarms for certain infusion pumps. Deerfield, Illinois–based Baxter warned that incorrect administration set setup and/or the incomplete resolution of upstream occlusion alarms may result in reduced delivery or non-delivery of medication. The problem might occur without the users receiving alerts […]

Filed Under: Drug Pumps, Drug-Device Combinations, Featured, News Well, Recalls, Regulatory/Compliance Tagged With: Baxter

Baxter profits up 42% in Q4

February 17, 2022 By Danielle Kirsh

Baxter (NYSE:BAX) today posted fourth-quarter results that beat the overall consensus on Wall Street. The Deerfield, Illinois-based company reported profits of $242 million, or 47¢ per share, on sales of $3.5 billion for the three months ended Dec. 31, 2021, for a bottom-line gain of 41.5% on sales growth of 10.5% compared with Q4 2020. Adjusted […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, News Well, Wall Street Beat Tagged With: Baxter

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 37
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy